Literature DB >> 19021358

Monitoring of hexyl 5-aminolevulinate-induced photodynamic therapy in rat bladder cancer by optical spectroscopy.

Eivind L P Larsen1, Lise L Randeberg, Odrun A Gederaas, Carl-Jørgen Arum, Astrid Hjelde, Chun-Mei Zhao, Duan Chen, Hans E Krokan, Lars O Svaasand.   

Abstract

Monitoring of the tissue response to photodynamic therapy (PDT) can provide important information to help optimize treatment variables such as drug and light dose, and possibly predict treatment outcome. A urinary bladder cancer cell line (AY-27) was used to induce orthotopic transitional cell carcinomas (TCC) in female Fischer rats, and hexyl 5-aminolevulinate (HAL, 8 mM, 1 h)-induced PDT was performed on day 14 after instillation of the cancer cells (20 J/cm(2) fluence at 635 nm). In vivo optical reflectance and fluorescence spectra were recorded from bladders before and after laser treatment with a fiberoptic probe. Calculated fluorescence bleaching and oxygen saturation in the bladder wall were examined and correlated to histology results. Reflectance spectra were analyzed using a three-layer optical photon transport model. Animals with TCC treated with PDT showed a clear treatment response; decreased tissue oxygenation and protoporphyrin IX (PpIX) fluorescence photobleaching were observed. Histology demonstrated that 3 of 6 animals with treatment had no sign of the tumor 7 days after PDT treatment. The other 3 animals had significantly reduced the tumor size. The most treatment-responsive animals had the highest PpIX fluorescence prior to light irradiation. Thus, optical spectroscopy can provide useful information for PDT. The model has proved to be very suitable for bladder cancer studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19021358     DOI: 10.1117/1.2967909

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  6 in total

1.  Intrinsic fluorescence of protoporphyrin IX from blood samples can yield information on the growth of prostate tumours.

Authors:  Flávia Rodrigues de Oliveira Silva; Maria Helena Bellini; Vivian Regina Tristão; Nestor Schor; Nilson Dias Vieira; Lilia Coronato Courrol
Journal:  J Fluoresc       Date:  2010-04-24       Impact factor: 2.217

2.  Increased Anticancer Efficacy of Intravesical Mitomycin C Therapy when Combined with a PCNA Targeting Peptide.

Authors:  Odrun A Gederaas; Caroline D Søgaard; Trond Viset; Siri Bachke; Per Bruheim; Carl-Jørgen Arum; Marit Otterlei
Journal:  Transl Oncol       Date:  2014-12       Impact factor: 4.243

3.  Early assessment of tumor response to photodynamic therapy using combined diffuse optical and diffuse correlation spectroscopy to predict treatment outcome.

Authors:  Patricia S P Thong; Kijoon Lee; Hui-Jin Toh; Jing Dong; Chuan-Sia Tee; Kar-Perng Low; Pui-Haan Chang; Ramaswamy Bhuvaneswari; Ngian-Chye Tan; Khee-Chee Soo
Journal:  Oncotarget       Date:  2017-03-21

4.  Amphiphilic Rhenium-Oxo Corroles as a New Class of Sensitizers for Photodynamic Therapy.

Authors:  Rune F Einrem; Abraham B Alemayehu; Sergey M Borisov; Abhik Ghosh; Odrun A Gederaas
Journal:  ACS Omega       Date:  2020-04-27

5.  "Two hits - one stone"; increased efficacy of cisplatin-based therapies by targeting PCNA's role in both DNA repair and cellular signaling.

Authors:  Caroline Krogh Søgaard; Augun Blindheim; Lisa M Røst; Voin Petrović; Anala Nepal; Siri Bachke; Nina-Beate Liabakk; Odrun A Gederaas; Trond Viset; Carl-Jørgen Arum; Per Bruheim; Marit Otterlei
Journal:  Oncotarget       Date:  2018-08-21

6.  Antitumor Effect and Induced Immune Response Following Exposure of Hexaminolevulinate and Blue Light in Combination with Checkpoint Inhibitor in an Orthotopic Model of Rat Bladder Cancer.

Authors:  Laureline Lamy; Jacques Thomas; Agnès Leroux; Jean-François Bisson; Kari Myren; Aslak Godal; Gry Stensrud; Lina Bezdetnaya
Journal:  Biomedicines       Date:  2022-02-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.